A new Series published in The Lancet describes how, although commercial entities can contribute positively to health and society, the products and practices of some commercial actors are responsible for escalating rates of ...
Mar 23, 2023
1
96
Do you ever think about what happens when we die, whether we have a soul, or what the meaning of life is? This—and much more—is what new research is shedding light on.
Mar 13, 2023
0
83
A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.
Mar 13, 2023
0
72
Contracting a lower respiratory tract infection in early childhood is associated with a higher risk of dying from respiratory disease as an adult, according to new research.
Mar 7, 2023
0
89
New evidence released today from a study of 31,245 patients already taking statin therapy indicates that inflammation may be a more powerful predictor of risk of future cardiovascular events—such as heart attack and stroke—than ...
Mar 6, 2023
0
150
In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according ...
Mar 6, 2023
0
153
Approximately one billion people are infected with influenza around the world each year, with more than half a million deaths estimated to result from the disease. Despite the disease's potential severity, especially among ...
Mar 6, 2023
0
55
Blood cancer patients, especially when they relapse, have a poor prognosis, and generally do not survive very long. The last five years have seen success in treating these patients with Chimeric Antigen Receptor (CAR) T-cells—a ...
Feb 24, 2023
0
50
Researchers said Tuesday they have identified a particularly severe form of mpox in people with advanced HIV which had a death rate of 15 percent among patients with AIDS.
Feb 21, 2023
0
88
Universitätsklinikum Erlangen is the first in the world to use CAR T-cells to successfully treat a patient suffering from a severe case of muscle inflammation (myositis). The disease is triggered by a malfunction in the ...
Feb 20, 2023
0
104
